[go: up one dir, main page]

SE8004744L - Nya tripeptidamider, som inverkar pa det centrala nervsystemet, jemte sett for deras framstellning - Google Patents

Nya tripeptidamider, som inverkar pa det centrala nervsystemet, jemte sett for deras framstellning

Info

Publication number
SE8004744L
SE8004744L SE8004744A SE8004744A SE8004744L SE 8004744 L SE8004744 L SE 8004744L SE 8004744 A SE8004744 A SE 8004744A SE 8004744 A SE8004744 A SE 8004744A SE 8004744 L SE8004744 L SE 8004744L
Authority
SE
Sweden
Prior art keywords
group
leucyl
nervous system
central nervous
new
Prior art date
Application number
SE8004744A
Other languages
English (en)
Other versions
SE447261B (sv
Inventor
L Kisfaludy
T Szirtes
L Balaspiri
E Palosi
L Sporny
A Sakardi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE8004744L publication Critical patent/SE8004744L/sv
Publication of SE447261B publication Critical patent/SE447261B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8004744A 1979-06-28 1980-06-26 Nya tripeptidamider, som inverkar pa det centrala nervsystemet SE447261B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79RI717A HU180925B (en) 1979-06-28 1979-06-28 Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem

Publications (2)

Publication Number Publication Date
SE8004744L true SE8004744L (sv) 1980-12-29
SE447261B SE447261B (sv) 1986-11-03

Family

ID=11001100

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004744A SE447261B (sv) 1979-06-28 1980-06-26 Nya tripeptidamider, som inverkar pa det centrala nervsystemet

Country Status (21)

Country Link
US (1) US4299821A (sv)
JP (1) JPS5636442A (sv)
AT (1) AT373578B (sv)
AU (1) AU538100B2 (sv)
BE (1) BE884014A (sv)
CA (1) CA1151154A (sv)
CH (1) CH650518A5 (sv)
CS (1) CS239907B2 (sv)
DD (1) DD151746A5 (sv)
DE (1) DE3024313A1 (sv)
DK (1) DK149611C (sv)
FI (1) FI74473C (sv)
FR (1) FR2460292A1 (sv)
GB (1) GB2058080B (sv)
HU (1) HU180925B (sv)
IL (1) IL60407A (sv)
IT (1) IT1150023B (sv)
NL (1) NL8003767A (sv)
PL (1) PL127100B1 (sv)
SE (1) SE447261B (sv)
SU (1) SU963463A3 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533209B1 (fr) * 1982-09-22 1985-11-08 Centre Nat Rech Scient Lipopeptides, leur obtention et leur application comme emulsifiants
WO1986003746A1 (en) * 1984-12-14 1986-07-03 La Trobe University Amino acid and peptide inhibitors of human leucocytic elastase
IT1186733B (it) * 1985-06-05 1987-12-16 Eniricerche Spa Composti tripeptidici ad azione ipotensiva
FR2597100A1 (fr) * 1986-01-21 1987-10-16 Nippon Shinyaku Co Ltd Derives du pyroglutamide
KR960705808A (ko) * 1993-11-09 1996-11-08 조셉 에프. 디프리마 성장 호르몬의 방출을 촉진시키는 피페리딘, 피롤리딘 및 헥사하이드로-1H-아제핀(Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone)
US5494919A (en) * 1993-11-09 1996-02-27 Merck & Co., Inc. 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
FR2733995B1 (fr) 1995-05-09 1997-07-25 Inst Nat Sante Rech Med Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments
DE19527575A1 (de) * 1995-07-28 1997-01-30 Basf Ag Verfahren zur Herstellung von peptidischer Wirkstoffe
US20050233973A1 (en) * 1997-10-09 2005-10-20 Albert Sattin Tri-peptides for antidepressant applications
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
LU73294A1 (sv) * 1975-09-02 1977-05-11

Also Published As

Publication number Publication date
IL60407A0 (en) 1980-09-16
IT1150023B (it) 1986-12-10
CH650518A5 (de) 1985-07-31
DK149611C (da) 1987-01-26
SU963463A3 (ru) 1982-09-30
NL8003767A (nl) 1980-12-30
SE447261B (sv) 1986-11-03
DE3024313C2 (sv) 1991-05-29
DK274680A (da) 1980-12-29
FI74473B (fi) 1987-10-30
CA1151154A (en) 1983-08-02
IL60407A (en) 1984-11-30
CS239907B2 (en) 1986-01-16
PL127100B1 (en) 1983-09-30
DD151746A5 (de) 1981-11-04
FI74473C (sv) 1988-02-08
AU538100B2 (en) 1984-07-26
DE3024313A1 (de) 1981-01-29
US4299821A (en) 1981-11-10
GB2058080A (en) 1981-04-08
JPS5636442A (en) 1981-04-09
FI802057A (fi) 1980-12-29
AT373578B (de) 1984-02-10
HU180925B (en) 1983-05-30
CS458480A2 (en) 1985-05-15
ATA334680A (de) 1983-06-15
DK149611B (da) 1986-08-11
FR2460292B1 (sv) 1983-11-18
GB2058080B (en) 1983-02-23
IT8023096A0 (it) 1980-06-26
PL225268A1 (sv) 1981-10-16
FR2460292A1 (fr) 1981-01-23
BE884014A (fr) 1980-12-29
AU5971980A (en) 1981-01-08

Similar Documents

Publication Publication Date Title
BRPI0608291A2 (pt) agente imunossupressor e agente antitumoral que compreendem composto heterocìclico como ingrediente ativo
SE8004744L (sv) Nya tripeptidamider, som inverkar pa det centrala nervsystemet, jemte sett for deras framstellning
BR0109703A (pt) Derivados de piperazina
BRPI0417771A (pt) heterociclos azabicìclicos como moduladores de receptor canabinóides
BR0113146A (pt) Derivados de prolina e uso destes como drogas
BR0311806A (pt) Derivados heteroaril benzocondensado-amida de tienopiridinas úteis como agentes terapêuticos, composições farmacêuticas que os incluem e métodos para o seu uso
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
BR0113234A (pt) Polimorfos de um análogo de epotilona
EA199901014A1 (ru) C-4"-замещенные макролидные производные
KR940007022A (ko) 피패리딘 유도체, 이것의 제법 및 치료에 있어서 이것의 이용
BRPI0615248A2 (pt) derivado tendo atividade agonista de ppar
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
ATE159250T1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
PT915894E (pt) Analogos de nucleotidos
DK0534445T3 (da) Fremgangsmåde til fremstilling af et lægemiddel til oral eller topisk administrering ved behandling af Leishmaniasis
BR9201854A (pt) Composto derivado de pridazinas,processo para sua preparacao,e,composicao farmaceutica
KR960007592A (ko) 신규한 피롤로카바졸
MX2023003846A (es) Compuesto de bifenilo como inmunomodulador, metodo de preparacion del mismo y aplicacion del mismo.
DK96783D0 (da) Fremgangsmade til fremstilling af 4''-epierythromycin a eller derivater deraf
BR0214180A (pt) Composições fungicidas, método de controle e produto
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
ATE371644T1 (de) Neues alkaloidderivat und dieses enthaltende pharmazeutische zusammensetzung
FI872236A0 (fi) Foerfarande foer framstaellning av synergistinderivat.
ATE445589T1 (de) Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
DK218388A (da) Aktivt princip isoleret fra hajvaev

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8004744-2

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8004744-2

Format of ref document f/p: F